Table 1.
Gene symbol | Gene name | Fold change* | |
---|---|---|---|
Hour 2 | Hour 8 | ||
Transcription and activation pathways | |||
BIRC3 | Baculoviral IAP repeat-containing protein 3 | 6.1 | 4.1 |
NFKBIA | Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | 36.1 | 10 |
NFKBIZ | Nuclear factor of kappa-B inhibitor zeta | 23.8 | 4.1 |
NFKB2 | Nuclear factor of κ light polypeptide gene enhancer in B-cells 2 | 2 | 2.1 |
Cytokines and chemokines, growth factors | |||
CCL2 | Chemokine (C-C motif) ligand 2 | 28.5 | 26.7 |
CCL5 | RANTES | 35.4 | 48.4 |
CCL20 | Chemokine (C-C motif) ligand 20 | 2034 | 1162.3 |
CSF2 | Colony stimulating factor 2 | 97 | 6.1 |
CXCL1 | Chemokine (C-X-C motif) ligand 1 | 2.5 | - - |
CXCL2 | Chemokine (C-X-C motif) ligand 2 | 43.8 | 27.1 |
CXCL5 | Chemokine (C-X-C motif) ligand 5 | 43.8 | 27.1 |
IFNB | Interferon beta precursor | 2 | 2 |
IL1A | Interleukin 1, alpha | 86.0 | 23.5 |
IL-6 | Interleukin 6 | 83 | 131.6 |
IL-8 | Interleukin 8 | 123.7 | 273.7 |
SAA3 | Serum Amyloid A 3 | 505.6 | 2498.3 |
TNF-a | Tumor Necrosis Factor, alpha | 125.2 | - - |
TNFSF13B | Tumor necrosis factor (ligand) superfamily, member 13 (BAFF) | - - | 4.6 |
Type I IFN-related genes | |||
IFI44 | Similar to Interferon-induced protein 44 | - - | 15.2 |
IFIH1 | Interferon induced with helicase C domain 1 | - - | 15.1 |
ISG15 | ubiquitin-like modifier | 6.2 | 63.2 |
MX2 | Myxovirus (influenza virus) resistance 2 | - - | 121.2 |
OAS1 | 2′-5′-oligoadenylate synthetase 1 | - - | 24.6 |
OAS2 | 2′-5′-oligoadenylate synthetase 2 | 2.8 | 26.1 |
TNFSF10 | Tumor necrosis factor ligand superfamily member 10 (TRAIL) | - - | 15.8 |
*Data obtained by RNA-Seq and presented as fold induction of the indicated gene at either 2 or 8 hours post-LPS in comparison to expression levels at 0 hours post-LPS. All fold changes shown are FDR < 0.05; FC > 2; and CPM >1. - - indicates FDR > 0.05, FC < 2, or CPM < 1.